Implandata

Hannover, Germany Founded: 2009 • Age: 17 yrs
Intraocular pressure is monitored continuously via an implantable microsensor.
Request Access

About Implandata

Implandata is a company based in Hannover (Germany) founded in 2009.. Implandata has raised $8.52 million across 6 funding rounds from investors including Heidelberg Engineering, KfW and OCCIDENT. The company has 9 employees as of December 31, 2021. Implandata offers products and services including eyemate®. Implandata operates in a competitive market with competitors including Sensimed, i-Optics, Inoveon, Azul Optics and Diopsys, among others.

  • Headquarter Hannover, Germany
  • Employees 9 as on 31 Dec, 2021
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Implandata Ophthalmic Products Gmbh
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $8.52 M (USD)

    in 6 rounds

  • Latest Funding Round
  • Investors
  • Employee Count
    9

    as on Dec 31, 2021

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Implandata

Implandata offers a comprehensive portfolio of products and services, including eyemate®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Implantable system for monitoring intraocular pressure in glaucoma patients.

People of Implandata
Headcount 10-50
Employee Profiles 6
Employee Profiles
People
Stefan Meyer
Co-founder & Technical Director
People
Kaweh Mansouri
Chief Medical Officer
People
Tido Van Hove
Development Engineer
People
Timo Wunsch
Junior Engineer R&D

Unlock access to complete

Funding Insights of Implandata

Implandata has successfully raised a total of $8.52M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round
  • First Round

    (21 Jun 2010)

  • Investors Count 9
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2018 Amount Series C - Implandata Valuation Heidelberg Engineering , OCCIDENT – The Science Investor.
KfW , HTGF
Jan, 2016 Amount Grant - Implandata Valuation

investors

Oct, 2014 Amount Series B - Implandata Valuation Born2Grow
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Implandata

Implandata has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Heidelberg Engineering, KfW and OCCIDENT. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital investments are provided to deep-tech startups.
Founded Year Domain Location
Early-stage investments are made in high-tech startups by HTGF.
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Implandata

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Implandata

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Implandata Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Implandata

Implandata operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sensimed, i-Optics, Inoveon, Azul Optics and Diopsys, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
A contact lens-based platform for glaucoma monitoring is offered.
domain founded_year HQ Location
i-Optics specializes in providing advanced retina and cornea imaging systems for medical professionals.
domain founded_year HQ Location
Eye disease detection services including diabetic retinopathy are provided.
domain founded_year HQ Location
Device for assessing the eye health against damaging light
domain founded_year HQ Location
Non-invasive visual electrophysiology devices are supplied for ophthalmological diagnosis.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Implandata

When was Implandata founded?

Implandata was founded in 2009 and raised its 1st funding round 1 year after it was founded.

Where is Implandata located?

Implandata is headquartered in Hannover, Germany. It is registered at Hannover, Niedersachsen, Germany.

Is Implandata a funded company?

Implandata is a funded company, having raised a total of $8.52M across 6 funding rounds to date. The company's 1st funding round was a Series B of $3.8M, raised on Jun 21, 2010.

How many employees does Implandata have?

As of Dec 31, 2021, the latest employee count at Implandata is 9.

What does Implandata do?

A medical device company focused on ophthalmology, Implandata Ophthalmic Products GmbH was founded in 2009 and is based in Hannover, Germany. The Eyemate system has been developed for telemetric measurement of intraocular pressure over 24 hours. This technology is utilized for monitoring and managing glaucoma in patients through a biocompatible implant. Operations center on device innovation for eye health diagnostics.

Who are the top competitors of Implandata?

Implandata's top competitors include 2EyesVision, Sensimed and Diopsys.

What products or services does Implandata offer?

Implandata offers eyemate®.

Who are Implandata's investors?

Implandata has 9 investors. Key investors include Heidelberg Engineering, KfW, OCCIDENT, nkb, and High-Tech Gründerfonds.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available